2023 ICD-10-CM Diagnosis Code E13.0

Other specified diabetes mellitus with hyperosmolarity

    2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
  • E13.0 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.
  • The 2023 edition of ICD-10-CM E13.0 became effective on October 1, 2022.
  • This is the American ICD-10-CM version of E13.0 - other international versions of ICD-10 E13.0 may differ.
The following code(s) above E13.0 contain annotation back-references
Annotation Back-References
In this context, annotation back-references refer to codes that contain:
  • Applicable To annotations, or
  • Code Also annotations, or
  • Code First annotations, or
  • Excludes1 annotations, or
  • Excludes2 annotations, or
  • Includes annotations, or
  • Note annotations, or
  • Use Additional annotations
that may be applicable to E13.0:
  • E00-E89
    2023 ICD-10-CM Range E00-E89

    Endocrine, nutritional and metabolic diseases

    Note
    • All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.
    Type 1 Excludes
    • transitory endocrine and metabolic disorders specific to newborn (P70-P74)
    Endocrine, nutritional and metabolic diseases
  • E13
    ICD-10-CM Diagnosis Code E13

    Other specified diabetes mellitus

      2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
    Includes
    • diabetes mellitus due to genetic defects of beta-cell function
    • diabetes mellitus due to genetic defects in insulin action
    • postpancreatectomy diabetes mellitus
    • postprocedural diabetes mellitus
    • secondary diabetes mellitus NEC
    Type 1 Excludes
    • diabetes (mellitus) due to autoimmune process (E10.-)
    • diabetes (mellitus) due to immune mediated pancreatic islet beta-cell destruction (E10.-)
    • diabetes mellitus due to underlying condition (E08.-)
    • drug or chemical induced diabetes mellitus (E09.-)
    • gestational diabetes (O24.4-)
    • neonatal diabetes mellitus (P70.2)
    • type 1 diabetes mellitus (E10.-)
    Use Additional
    • code to identify control using:
    • insulin (Z79.4)
    • oral antidiabetic drugs (Z79.84)
    • oral hypoglycemic drugs (Z79.84)
    Other specified diabetes mellitus
Code History
  • 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
  • 2017 (effective 10/1/2016): No change
  • 2018 (effective 10/1/2017): No change
  • 2019 (effective 10/1/2018): No change
  • 2020 (effective 10/1/2019): No change
  • 2021 (effective 10/1/2020): No change
  • 2022 (effective 10/1/2021): No change
  • 2023 (effective 10/1/2022): No change
ICD-10-CM Codes Adjacent To E13.0
E11.630 Type 2 diabetes mellitus with periodontal disease
E11.638 Type 2 diabetes mellitus with other oral complications
E11.64 Type 2 diabetes mellitus with hypoglycemia
E11.641 …… with coma
E11.649 …… without coma
E11.65 Type 2 diabetes mellitus with hyperglycemia
E11.69 Type 2 diabetes mellitus with other specified complication
E11.8 Type 2 diabetes mellitus with unspecified complications
E11.9 Type 2 diabetes mellitus without complications
E13 Other specified diabetes mellitus
E13.0 Other specified diabetes mellitus with hyperosmolarity
E13.00 …… without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)
E13.01 …… with coma
E13.1 Other specified diabetes mellitus with ketoacidosis
E13.10 …… without coma
E13.11 …… with coma
E13.2 Other specified diabetes mellitus with kidney complications
E13.21 Other specified diabetes mellitus with diabetic nephropathy
E13.22 Other specified diabetes mellitus with diabetic chronic kidney disease
E13.29 Other specified diabetes mellitus with other diabetic kidney complication
E13.3 Other specified diabetes mellitus with ophthalmic complications

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.